by DAVID.KIEWLICH | Sep 10, 2026 | Biotech Lab Access
Your data won’t care whether you had unrestricted access to lab equipment. But your ability to generate that data will. In 2026, raising seed and Series A funding is tough. Investors are asking for data. Sometimes even proof-of-concept data at seed stage. And in order...
by DAVID.KIEWLICH | Sep 3, 2026 | Biotech
Starting a biotech company is hard enough. Between funding and the burn rate, hitting milestones, and regulatory requirements, founder loneliness can become too much to bear. One factor that contributes to loneliness in founders is the space itself. If you can get a...
by DAVID.KIEWLICH | Aug 28, 2026 | Biotech
You found something new in the lab. Maybe it’s a new cell therapy target, a bio manufacturing process that could drastically reduce the price of a life saving medicine, or a battery material that could completely change how we store electricity. You have the results,...
by DAVID.KIEWLICH | Aug 21, 2026 | Biotech
Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...
by DAVID.KIEWLICH | Aug 20, 2026 | Biotech
It’s 2:47am. Your cells have reached the exact confluence you need for your assay. Your PCR is done running. Your western blot is ready to image. You have the data you’ve been trying to get for 3 months, and you need to review it. The problem? You’re not allowed...
